Literature DB >> 12022316

Cost of joint replacement surgery for osteoarthritis: the patients' perspective.

Lyn March1, Marita Cross, Kate Tribe, Helen Lapsley, Brett Courtenay, Peter Brooks.   

Abstract

OBJECTIVE: To address costs of total joint replacement surgery from the patients' perspective by determining patient out-of-pocket costs during the first year following joint replacement, and to explore whether health status presurgery or in the immediate 3 months postsurgery were determinants of costs. In light of the different outcomes experienced by patients with total knee replacement (TKR) and total hip replacement (THR), any differences in costs between the 2 groups were also explored.
METHODS: Patients with osteoarthritis (OA) scheduled for primary unilateral TKR or THR surgery at 3 Sydney hospitals were approached. Patients completed questionnaires preoperatively to record expenses during the previous 3 months and health status immediately prior to surgery. Patients then maintained detailed prospective cost diaries and completed SF-36 and WOMAC Index every 3 months for the first postoperative year. Arthritis-specific cost inforrmation obtained in the diary included medications (prescription and nonprescription), visits to health professionals, tests (radiographs, scans, blood tests, etc), special equipment, alterations to house, and the use of private or community services.
RESULTS: Ninety-eight TKR and 76 THR patients provided cost details for their first postoperative year. For both THR and TKR patients, out-of-pocket costs fell considerably over the first postoperative year, and during the year the proportion of patients who experienced no out-of-pocket costs increased, as did the proportion who made no use of health services such as medical tests or visits to health professionals. Regression analysis for THR patients showed that pension status, preoperative SF-36 Physical Component Score, and 3-month postoperative WOMAC Function were significant independent predictors of postoperative costs. Regression analysis for TKR patients showed that presurgery WOMAC Stiffness and pension status were significant independent predictors of postoperative costs, indicating that those with greater stiffness had greater postsurgery costs and those on a pension had lower costs.
CONCLUSION: OA patients undergoing THR and TKR have substantial out-of-pocket costs presurgery, which fall dramatically over the first postoperative year. Poorer presurgery health status predicted greater expenditure during the first postoperative year, which might be taken into consideration when patients are making a choice about the timing of joint surgery.

Entities:  

Mesh:

Year:  2002        PMID: 12022316

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  21 in total

Review 1.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Comparison of lifetime incremental cost:utility ratios of surgery relative to failed medical management for the treatment of hip, knee and spine osteoarthritis modelled using 2-year postsurgical values.

Authors:  Peggy Tso; Kevin Walker; Nizar Mahomed; Peter C Coyte; Y Raja Rampersaud
Journal:  Can J Surg       Date:  2012-06       Impact factor: 2.089

3.  Early Clinically Relevant Improvement in Quality of Life and Clinical Outcomes 1 Year Postsurgery in Patients with Knee and Hip Joint Arthroplasties.

Authors:  Audrey Neuprez; Arnaud H Neuprez; Jean-François Kaux; William Kurth; Christophe Daniel; Thierry Thirion; Jean-Pierre Huskin; Philippe Gillet; Olivier Bruyère; Jean-Yves Reginster
Journal:  Cartilage       Date:  2017-12-21       Impact factor: 4.634

4.  The First SICOT Oral Presentation Award 2011: imageless computer-assisted femoral component positioning in hip resurfacing: a prospective randomised trial.

Authors:  Maik Stiehler; Jens Goronzy; Albrecht Hartmann; Frank Krummenauer; Klaus-Peter Günther
Journal:  Int Orthop       Date:  2013-02-06       Impact factor: 3.075

5.  Use of complementary medicines for osteoarthritis--a prospective study.

Authors:  J Zochling; L March; H Lapsley; M Cross; K Tribe; P Brooks
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

6.  Comparison of total hip and knee joint replacement in patients with rheumatoid arthritis and osteoarthritis: a nationwide, population-based study.

Authors:  Chi-Yang Liao; Hui-Ting Chan; En Chao; Che-Ming Yang; Tzu-Chuan Lu
Journal:  Singapore Med J       Date:  2015-01       Impact factor: 1.858

7.  Clinical predictors of elective total joint replacement in persons with end-stage knee osteoarthritis.

Authors:  Joseph A Zeni; Michael J Axe; Lynn Snyder-Mackler
Journal:  BMC Musculoskelet Disord       Date:  2010-05-06       Impact factor: 2.362

8.  Hospital costs of total hip arthroplasty for developmental dysplasia of the hip.

Authors:  Ali Ashraf; A Noelle Larson; Hilal Maradit-Kremers; Walter K Kremers; David G Lewallen
Journal:  Clin Orthop Relat Res       Date:  2014-04-11       Impact factor: 4.176

9.  Costs and outcomes of total hip and knee joint replacement for rheumatoid arthritis.

Authors:  L M March; A L Barcenilla; M J Cross; H M Lapsley; D Parker; P M Brooks
Journal:  Clin Rheumatol       Date:  2008-05-24       Impact factor: 2.980

10.  Determinants of direct medical costs in primary and revision total knee arthroplasty.

Authors:  Hilal Maradit Kremers; Sue L Visscher; James P Moriarty; Megan S Reinalda; Walter K Kremers; James M Naessens; David G Lewallen
Journal:  Clin Orthop Relat Res       Date:  2013-01       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.